TRENDS IN INCIDENCE AND PREVALENCE OF HIV-1 INFECTION IN INTRAVENOUS-DRUG-USERS IN VALENCIA, SPAIN

被引:22
作者
REBAGLIATO, M
AVINO, MJ
HERNANDEZAGUADO, I
RUIZ, I
PEREZHOYOS, S
BOLUMAR, F
FERRER, L
机构
[1] IVESP,E-46017 VALENCIA,SPAIN
[2] UNIV ALICANTE,DEPT SALUD PUBL,E-03080 ALACANT,SPAIN
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1995年 / 8卷 / 03期
关键词
HIV; AIDS; INTRAVENOUS DRUG USERS; PREVALENCE; INCIDENCE;
D O I
10.1097/00042560-199503010-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Our objective was to describe and compare the trends of incidence and prevalence of HIV-1 infection in intravenous drug users (IDUs) in Valencia, Spain in 1987-1992. A cohort study was carried out in AIDS Information Centers located in the Valencia Region (Spain). Point seroprevalence was calculated for each year according to HIV status at the first contact. Incidence annual rates were calculated from those IDUs identified as seronegative in their first visit and who returned for a new testing. From a total of 4,207 IDUs who contacted these centers, 4,131 (98.2%) asked voluntarily for HIV-1 testing. The seroprevalence for the whole period was 48.4% (95% C.I., 46.88, 49.92). Follow-up information was available for 604 subjects of the total 2,130 subjects who were seronegative in their first visit. The incidence rate for the 1988-1992 period was 12.02/100 person-years (95% C.I., 9.62, 14.41). Prevalence showed an overall decreasing pattern with a minimum corresponding to the year 1992 (43.6%). Incidence rates increased mildly until 1990 (13.93 per 100 person-years), to stabilize beyond at similar to 10 per 100 person-years. Our incidence rates are very high regardless of the decline of prevalence. Effective risk reduction programs among IDUs have been almost nonexistent in Spain up to now and should become an immediate priority.
引用
收藏
页码:297 / 301
页数:5
相关论文
共 15 条
[1]  
AGUADO IH, 1993, MED CLIN-BARCELONA, V100, P164
[2]  
AGUADO IH, 1993, INT J EPIDEMIOL, V22, P537
[3]  
AGUADO IH, 1994, INT J EPIDEMIOL, V23, P602
[4]  
DESJARLAIS D, 1992, AIDS, V6, P1052
[5]   HIV-1 INFECTION AMONG INTRAVENOUS DRUG-USERS IN MANHATTAN, NEW-YORK-CITY, FROM 1977 THROUGH 1987 [J].
DESJARLAIS, DC ;
FRIEDMAN, SR ;
NOVICK, DM ;
SOTHERAN, JL ;
THOMAS, P ;
YANCOVITZ, SR ;
MILDVAN, D ;
WEBER, J ;
KREEK, MJ ;
MASLANSKY, R ;
BARTELME, S ;
SPIRA, T ;
MARMOR, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (07) :1008-1012
[6]   PREVALENCE OF HIV INFECTION AMONG INTRAVENOUS DRUG-USERS IN THE UNITED-STATES [J].
HAHN, RA ;
ONORATO, IM ;
JONES, TS ;
DOUGHERTY, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (18) :2677-2684
[7]  
NICOLOSI A, 1992, J ACQ IMMUN DEF SYND, V5, P365
[8]   PARENTERAL AND SEXUAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN INTRAVENOUS-DRUG-USERS - A STUDY OF SEROCONVERSION [J].
NICOLOSI, A ;
LEITE, MLC ;
MUSICCO, M ;
MOLINARI, S ;
LAZZARIN, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (03) :225-233
[9]  
OLMEDO MG, 1990, MED CLIN-BARCELONA, V95, P286
[10]  
RICO MJA, 1994, MED CLIN-BARCELONA, V102, P369